Modelling Ser129 Phosphorylation Inhibits Membrane Binding of Pore-Forming Alpha-Synuclein Oligomers by Nübling, Georg Sebastian et al.
Modelling Ser129 Phosphorylation Inhibits Membrane
Binding of Pore-Forming Alpha-Synuclein Oligomers
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Tobias Högen1, Frits Kamp5, Armin Giese2
1 Department of Neurology, Klinikum der Universität München, Ludwig-Maximilians-University, Munich, Germany, 2 Center for Neuropathology and Prion Research,
Ludwig-Maximilians-University, Munich, Germany, 3 Department of Palliative Medicine, Klinikum der Universität München, Ludwig-Maximilians-University, Munich,
Germany, 4 Endowed Professorship for Interdisciplinary Research in Palliative Care, Institute of Nursing Science and –Practice, Paracelsus Medical University, Salzburg,
Austria, 5 Adolf-Butenandt-Institute, Munich, Germany
Abstract
Background: In several neurodegenerative diseases, hyperphosphorylation at position Ser129 is found in fibrillar deposits of
alpha-synuclein (asyn), implying a pathophysiological role of asyn phosphorylation in neurodegeneration. However, recent
animal models applying asyn phosphorylation mimics demonstrated a protective effect of phosphorylation. Since metal-ion
induced asyn oligomers were identified as a potential neurotoxic aggregate species with membrane pore-forming abilities,
the current study was undertaken to determine effects of asyn phosphorylation on oligomer membrane binding.
Methods: We investigated the influence of S129 phosphorylation on interactions of metal-ion induced asyn oligomers with
small unilamellar lipid vesicles (SUV) composed of POPC and DPPC applying the phosphorylation mimic asyn129E. Confocal
single-particle fluorescence techniques were used to monitor membrane binding at the single-particle level.
Results: Binding of asyn129E monomers to gel-state membranes (DPPC-SUV) is slightly reduced compared to wild-type
asyn, while no interactions with membranes in the liquid-crystalline state (POPC-SUV) are seen for both asyn and asyn129E.
Conversely, metal-ion induced oligomer formation is markedly increased in asyn129E. Surprisingly, membrane binding to
POPC-SUV is nearly absent in Fe3+ induced asyn129E oligomers and markedly reduced in Al3+ induced oligomers.
Conclusion: The protective effect of pseudophosphorylation seen in animal models may be due to impeded oligomer
membrane binding. Phosphorylation at Ser129 may thus have a protective effect against neurotoxic asyn oligomers by
preventing oligomer membrane binding and disruption of the cellular electrophysiological equilibrium. Importantly, these
findings put a new complexion on experimental pharmaceutical interventions against POLO-2 kinase.
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Introduction
Fibrillar deposits of alpha-synuclein are the pathological
hallmark of several neurodegenerative diseases such as Parkinson’s
disease (PD) and multiple systems atrophy (MSA). In PD, the
progressive spreading of Lewy bodies to different brain areas
coincides with clinical disease progression [1]. In recent years,
there is increasing evidence that smaller alpha-synuclein (asyn)
oligomers, which are en route to fibril formation, are the key
neurotoxic aggregate species [2–5]. However, the circumstances
leading to the formation of these oligomers as well as their toxic
mode of action remains unclear.
Increasing evidence suggests that interactions between asyn and
lipid membranes may be essential to asyn function and neurotox-
icity [6–8]. However, these interactions appear to be complex.
Concerning physiological protein function, it was shown that asyn
physiologically interacts with vesicles at the presynaptic terminals,
regulating vesicle traffic [9,10]. In asyn monomers, membrane
interactions are mediated through KTKEGV repeats at the N-
terminus [11–13]. Such interactions might be related to the
protein’s native function, stabilizing lipid packing and reducing
membrane fusion [14]. On the other hand, several models have
shown a neurotoxic effect of asyn membrane binding [15,16].
Furthermore, asyn membrane binding has been suggested to favor
oligomer formation and subsequent disruption of membrane
integrity [17,18]. To date, it is not fully understood which forms of
asyn membrane interactions lead to toxicity, and whether
oligomer formation is a result of or a requirement for pathologic
membrane interactions. To address this issue, we previously
performed experiments using single-particle fluorescence tech-
niques, which allow distinguishing between monomer and
oligomer binding to membranes. By this approach, we were able
to demonstrate that asyn binding to lipid vesicles inhibits oligomer
formation, whereas oligomers show enhanced binding to lipid
membranes and may act as membrane pores [6,7]. These data
further substantiate the hypothesis that interactions of asyn
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oligomers with cellular membranes are the key toxic event in
synucleinopathies.
Another ongoing controversy concerns the role of asyn
phosphorylation in neurotoxicity. Phosphorylation at Ser129 is
abundant in Lewy bodies [19,20], while the phosphorylation rate
of asyn at this position appears to be low in the healthy
mammalian brain. To date, both pro- [20–22] and anti-
aggregatory effects [23,24] of asyn phosphorylation and phos-
phorylation-mimicking mutations have been observed in vitro and
in animal models. However, the role of asyn phosphorylation is
not limited to modulating aggregation behavior. Several lines of
evidence point towards an inhibiting effect of asyn phosphoryla-
tion on membrane binding. For example, in both budding yeast
and transgenic C. elegans, binding of asyn to plasma membranes is
enhanced for the phosphorylation-deficient S129A mutation,
while the phosphorylation mimicking S129D mutation results in
decreased membrane binding [16,25]. However, it is currently
unknown how phosphorylation modulates membrane binding, i.e.
whether it affects physiological monomer binding and/or mem-
brane interactions of disease-associated asyn oligomers.
The current study aimed at elucidating the influence of
phosphorylation on interactions of asyn monomers and potentially
toxic oligomers with model lipid membranes. Based on earlier
findings from histopathological, epidemiological and experimental
studies implicating an involvement of ferric iron in the pathogen-
esis of synucleinopathies, we have established a model of asyn
oligomer formation yielding potentially toxic aggregates in
presence of ferric iron [26–28]. We demonstrated that physiolog-
ical concentrations of ferric iron result in the formation of a
specific asyn oligomer species even at nanomolar protein
concentrations [6]. Furthermore, these oligomers have been
shown to interact with lipid membranes and may act as membrane
pores, possibly disrupting the transmembranous electrophysiolog-
ical equilibrium [6–8,29].
Here, we applied single-particle fluorescence techniques to
monitor the binding of monomers and metal-ion induced
oligomers of recombinant human asyn and the phosphorylation-
mimicking mutant asyn129E to small unilamellar lipid vesicles
(SUV). SUV were composed of 1-palmitoyl-2-oleoyl-sn-glycero-3-
phosphocholine (POPC) or dipalmitoylphosphatidylcholine
(DPPC), yielding lipid membranes in the liquid-crystalline or gel
state at room temperature, respectively. By using fluorophores
with two different excitation wavelengths, fluorescence correlation
spectroscopy (FCS) and scanning for intensely fluorescent targets
(SIFT) allow for the simultaneous detection of two different
particle types, thus enabling us to monitor particle interactions and
rare oligomers down to attomolar concentrations [30,31].
Materials and Methods
Expression and fluorescence labeling of recombinant
human alpha-synuclein and pseudophosphorylation
mutants S129D/E
Recombinant human alpha-synuclein was expressed in E.coli
and purified as described previously [32]. A stock solution of
1 mg/ml was prepared in tris buffer pH 7.0, 50 mM.
alpha-Synuclein pseudophosphorylation mutants S129E were a
kind gift of Prof. Dr. Philipp Kahle (Hertie Institut für klinische
Hirnforschung, Tübingen, Germany).
Fluorescence labeling
Human recombinant proteins asyn and asyn129E were
fluorescently labeled with Alexa-647-O-succinimidylester as de-
scribed previously [32]. Labeling ratios of dye to protein were 2:1.
Generation of small unilamellar lipid vesicles
Small unilamellar vesicles (SUV) were prepared from 1-
palmitoyl-2-oleoyl-sn-glycero-3-phosphocholine (POPC) or dipal-
mitoylphosphatidylcholine (DPPC) as described previously [7]. In
brief, a fluorescent lipid dye (Bodipy-PE, Invitrogen, Carlsbad,
CA) was mixed with POPC or DPPC in chloroform. Lipids were
dried by nitrogen gas evaporation, followed by hydration in buffer
and sonication. A vesicle diameter of 25–35 nm was confirmed by
dynamic light scattering (High Performance Particles Sizer,
Malvern Instruments, Herrenberg, Germany). SUV stock solu-
tions (lipid concentration: 100 mM) were stored at 4uC and used
within 48 hours.
Aggregation assay
Protein stock solutions were diluted to a final concentration of
10–20 nM (10–20 particles per focus volume) and coincubated
with Fe3+ or Al3+ at a final concentration of 10 mM for one hour in
a total sample volume of 20 ml to induce oligomer formation.
Subsequently, POPC-SUV or DPPC-SUV then added at a final
lipid concentration of 10 mM. SIFT measurements were started
after 30 minutes incubation time. Five measurements were
performed on four independent samples per measurement group.
Measurement time was 10 s. Measurements were carried out on
an Insight Reader (Evotec Technologies, Hamburg, Germany) in
384 well glass-bottom sample plates (Greiner Bioplates, Greiner,
Solingen, Germany) as described previously [7].
Analysis of protein aggregation and membrane binding
Protein aggregation was analyzed as described previously using
the software packages SIFT-2D and FCSPPEval Version 2.0
(Evotec Technologies, Hamburg, Germany) [33]. In brief, photons
per channel were summarized in time intervals (bins) of 40 ms and
plotted in a 2D FIDA (fluorescence intensity distribution analysis)
histogram. Histograms depicted in this paper contain all photons
of all consecutive measurements of one sample. Bin-weighted
SIFT aggregation and coaggregation analysis was performed as
described previously [33]. A threshold (T) was determined by
examining brightness in monomer samples. Oligomer signal was
defined as all photons (N) exceeding the threshold (N.T).
To determine oligomer brightness and size, asyn and asyn129E
monomer brightness (Qmonomer) was determined by a 1D FIDA
one component fit in a sample without aggregation inducers as
described previously [7]. Subsequently, oligomer brightness
(Qoligomer) was determined in a 1D FIDA two component fit
applying the previously determined monomer brightness as fixed
variable. Oligomer size (Xoligomer) was then calculated by
Xoligomer = Qoligomer/Qmonomer. The oligomer fraction of the
protein solution was calculated by FIDA two component fit
applying the formula c2q2/(c1q1/c2q2) (c1/2 = monomer/oligomer
concentration; q1/2 = monomer/oligomer brightness).
To determine the brightness of vesicles with bound monomers,
2D-FIDA analysis was performed. Therefore, monomer and
vesicle brightness were determined as stated above. Subsequently,
the brightness and concentration of bicolored particles was
determined by a three component 2D FIDA fit with a pre-set
particle brightness in both channels for component one (free asyn
monomer) and two (vesicle without bound monomers) and in
channel one for the third component (fixed vesicle brightness, free
fit of brightness for bound asyn). From the resulting brightness and
concentration of the third component, the total fluorescence
derived from bicolored particles in the red channel (i.e. asyn) was
calculated as Xbicolored = Cbicolored*Qbicolored.
Protein binding to lipid vesicles was analyzed applying the
SIFT-2D software package. Again, monomer brightness was
Phosphorylation Inhibits Membrane Binding of Alpha-Synuclein Oligomers
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determined, and an artificial neutral point was defined to exclude
vesicles and unbound oligomers. Membrane bound oligomers
could thus be identified as Vnbound: x.0 > y.0. Since unbound
oligmers are depicted along the ordinate of 2D FIDA histograms,
they can be identified as Vn unbound: x,0 > y.0. The percentage
of bound oligomers is thus identified as Nbound/(Nbound + Nunbound).
Statistical analysis
Normal distribution of data was evaluated by Shapiro-Wilks-
Test. Data are displayed as mean 6 standard deviation, except for
SIFT analyses which are displayed as mean 6 standard error of
the mean. Levels of significance were determined by student’s
t-test with Bonferroni adjustment for multiple testing where
appropriate. Significance was determined at an a-level of p,0.05.
All statistical analyses were performed with the software package
SPSS version 20.
Results
1. Pseudophosphorylation at Ser129 mildly reduces asyn
monomer binding to lipid vesicles
To investigate the influence of pseudophosphorylation at
Ser129 on asyn monomer binding to lipid vesicles, fluorescently
labeled asyn647 and asyn129E647 (‘‘red’’ channel) were coincu-
bated with POPC- and DPPC-SUV488 (‘‘green’’ channel) and
measured by SIFT. Data were depicted as 2D FIDA histograms,
with monomers resulting in data points near the origin of the
histogram, while asyn oligomers and vesicles labeled with multiple
fluorophores result in signal along the ordinate and the abscissa of
the histogram, respectively. Vesicle-bound monomers and oligo-
mers are represented along the bisectrix of the histogram (also see
the schematic in figure 1 A, adapted from [7]).
In the first set of experiments, no interactions of asyn/asyn129E
monomers and POPC-SUV were seen, while both asyn and
asyn129E readily bound to DPPC-SUV (figure 1 B). To
investigate whether binding to DPPC-SUV induces the formation
of asyn oligomers, the ionic detergent sodium-dodecyl-sulfate
(SDS) was added to the assay after the first set of measurements.
After dissolution of lipid vesicles with SDS at a final concentration
of 0.2%, only a low-intensity signal remained in both channels,
indicating that no SDS-resistant oligomers were formed upon asyn
binding to DPPC-SUV. In this experimental setup, asyn129E
exhibited a similar pattern of interaction with POPC- and DPPC-
SUV as asyn, although a mildly reduced DPPC vesicle binding
was seen (see figure 1 C). Fluorescence intensity distribution
analysis (FIDA) showed that particle brightness in the red channel
(asyn647) was unchanged upon coincubation of asyn and POPC-
SUV, while an approximately twofold increase in particle
brightness was seen upon coincubation with DPPC-SUV (figure 1
E). Furthermore, 2D-FIDA analysis demonstrated that the total
brightness of vesicle-bound monomers is mildly higher for asyn as
compared to asyn129E (figure 1 D). In this analysis, monomer and
vesicle brightness are first determined in control samples. In a
second step, these parameters are used to calculate the brightness
and concentration of bicolored particles. The fitted single-particle
brightness was also higher for asyn, demonstrating that bicolored
particles contain on average more asyn monomers as compared to
asyn129E (figure 1 D, single vesicle brightness). Further indicative of
the binding of multiple asyn monomers to one vesicle, particle
brightness was reduced to control levels upon coincubation with
SDS (figure 1 E), which readily dissolves DPPC-SUV, thus
liberating bound monomers. Of note, no asyn oligomers are found
after dissolution of DPPC-SUV. A similar, but less pronounced
effect was seen for asyn129E.
2. Pseudophosphorylation at Ser129 increases metal-ion
induced asyn oligomer formation
It was previously shown that physiological concentrations of
ferric iron induce the formation of a distinct, SDS-resistant asyn
oligomer species [6,7,34]. In our experiments, pseudophosphor-
ylation at position Ser129 markedly increased asyn oligomer
formation in presence of 10 mM Fe3+ and Al3+. As determined by
1D-FIDA two component analysis, the fraction of asyn incorpo-
rated in oligomers was higher for asyn129E (see figure 2 A). Of
note, the presence of ferric iron in concentrations up to 100 mM
did not alter the properties of the fluorescence dyes (see figure S1
A, B). Both FCS and FIDA analyses showed that total brightness
of the dye in solution, single particle brightness and diffusion time
remain unaltered by presence of metal ions (figure S1 A, B, D). In
addition, these parameters remained unchanged upon addition of
ferric iron to a solution containing a fluorescently labeled non-
amyloidogenic protein, in this case the asyn specific antibody
15G7 (figure S1 C). To examine possible effects of random asyn
labeling on oligomer formation, a control experiment applying
modified asyn proteins with point mutations to cysteine at
positions 3, 81 and 140 and subsequent point-specific labeling
with Alexa-647 maleimide dyes was performed. In this experi-
ment, monomers of all asyn mutations showed similar FCS signals
with comparable diffusion times (figure S1 F). Furthermore, 1D-
FIDA analysis of Fe3+ induced asyn oligomers yielded comparable
oligomer sizes for all labeling sites (figure S1 E), which were well in
accordance with oligomer sizes of randomly labeled asyn as
presented earlier [35]. Of note, earlier studies applying atomic
force microscopy also found similar sizes of metal ion induced
oligomers of unlabeled and randomly labeled asyn [6].
Concerning the effect of asyn pseudophosphorylation, FIDA
analysis showed an increase in the oligomer fraction in asyn129E
for both Fe3+ and Al3+, indicating an augmented aggregation
propensity for asyn129E under these conditions (see figure 2 A). In
contrast, oligomer sizes as determined by 1D-FIDA two compo-
nent fit are not significantly altered by pseudophosphorylation,
ranging from 116 to 143 monomers per oligomer for Fe3+ and
from 125 to 158 monomers per oligomer for Al3+ (also see figure 2
B).
3. Binding to lipid membranes composed of POPC is a
common hallmark of asyn oligomers induced by trivalent
metal-ions
We previously reported that Fe3+ induced asyn oligomers show
a gain of function compared to monomers by binding to SUV
composed of POPC. Since Al3+ proved to be a more potent
inducer of asyn oligomer formation, subsequent experiments were
undertaken to compare the binding behavior of asyn oligomers
induced by Fe3+ and Al3+. As is demonstrated in figure 3 A, Al3+
induced asyn oligomers showed an overall higher propensity to
bind to POPC-SUV as compared to oligomers formed in presence
of Fe3+ as determined by FIDA analysis.
4. Inhibition of asyn oligomer membrane binding by
pseudophosphorylation at Ser129
In this set of experiments, we investigated the influence of
pseudophosphorylation at Ser129 on oligomer vesicle interactions.
While metal ion induced asyn oligomers exhibited strong binding
to POPC-SUV, binding of Fe3+ induced oligomers was almost
abolished (,5% bound oligomers) in asyn129E, and binding of
Al3+ induced oligomers was markedly reduced (,20% bound
oligomers, see figure 3 A). In two control experiments, the size of
asyn/asyn129E oligomers formed in presence of POPC-SUV
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(asyn/asyn129E: 116/134 monomers per oligomer) remained
unchanged compared to oligomers generated in absence of SUV
(asyn/asyn129E: 112/147 monomers per oligomer) as determined
by FIDA analysis. SIFT segment analysis further corroborated a
reduced binding capacity of asyn129E oligomers as compared to
asyn (figure 3 B). As indicated in figure 1 A, this analysis allows to
depict the distribution and mixing ratio of bicolored aggregates.
For the phosphorylation mimic asyn129E, the amount of
bicolored particles (found in segments 4–15) is strongly reduced
for both Al3+- and Fe3+-induced oligomers indicating strongly
reduced membrane binding of these oligomers.
Discussion
In the recent decade, the increasing knowledge of asyn
aggregation behavior has shifted the scientific focus from the
histopathologically visible fibrillar aggregates to small oligomer
species. Dissecting the complex pathways of asyn oligomer
formation and interactions of these oligomers with lipid mem-
branes appears to be crucial to the understanding of synucleino-
pathies.
Influence of phosphorylation-mimicking mutations on
asyn oligomer formation
To date, both pro- [20–22] and anti-aggregatory effects [23,24]
of asyn phosphorylation and pseudophosphorylation have been
observed in vitro and in vivo. In the present study, we applied
fluorescently labeled asyn to investigate the influence of pseudo-
phosphorylation at position Ser129 (asyn129E) on oligomer
formation. In the absence of aggregation inducers, both asyn
and asyn129E showed no spontaneous oligomer formation at
nanomolar protein concentrations. The low concentrations
applied in these experiments may account for the fact that this
result is different from previous studies that reported increased
aggregation of phosphorylated asyn, since it is known that high
concentrations of asyn are required to enable spontaneous fibril
formation.
Remarkably, the current study further demonstrates that
asyn129E oligomer formation is largely increased as compared
to wild-type protein upon coincubation with both Fe3+ and Al3+.
The resulting oligomers did not differ in size compared to the
unphosphorylated protein, with each oligomer containing approx-
imately 115 to 160 monomers as determined by fluorescence
intensity distribution analysis, which is in accordance with
previous findings [6]. Interestingly, we recently demonstrated that
phosphorylation of tau by Glycogen Synthase Kinase 3b enhances
both metal-ion induced oligomer formation and coaggregation
with asyn [33,35]. The results presented here substantiate the
hypothesis that phosphorylation facilitates metal-ion induced
oligomer formation in amyloidogenic proteins at protein concen-
trations that likely resemble conditions in early states of disease. It
was speculated that the positively charged metal ions facilitate
protein interactions via the additional negative charges introduced
to the protein structure through phosphorylation [36].
Figure 1. Effect of Ser129 pseudophosphorylation on asyn monomer binding to lipid vesicles. aSyn647 and asyn129E647 were
coincubated with POPC- and DPPC-SUV488. Schematic A. demonstrates the appearance of vesicles, protein monomers and oligomers in 2D FIDA
histograms (adapted from [7]). B. aSyn647 and asyn129E647 monomers show no interactions with POPC-SUV. Conversely, extensive monomer binding
to DPPC-SUV is seen irrespective of pseudophosphorylation status. C. Quantitative FIDA analysis shows a mild tendency towards reduced vesicle
binding of asyn129E647. D. Quantitative 2D-FIDA analysis of monomers bound to DPPC-SUV demonstrates an overall higher amount of bound
monomers (total brightness), determined through brightness and concentration of bicolored particles. Furthermore, the higher fluorescence intensity
of the bicolored particles (single vesicle brightness) indicates that more monomers are bound per vesicle. E. In a control experiment, asyn647 and
asyn129E647 particle brightness (Q) as determined by 1D FIDA analysis (one component fit) is unchanged in presence of POPC-SUV as compared to
control measurements in the absence of vesicles, confirming that no membrane binding takes place. However, Q increases in presence of DPPC-SUV.
Dissolution of DPPC-SUV by SDS yields an asyn647 particle brightness similar to monomeric asyn647, indicating that oligomer formation is not induced
by binding to DPPC-SUV. Levels of significance are depicted as * = p,0.05; n = 3.
doi:10.1371/journal.pone.0098906.g001
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Modeling phosphorylation at Ser129 has a mild influence
on monomer binding to lipid membranes
Membrane binding of asyn is a complex interaction of various
factors including lipid composition, membrane curvature, and
posttranslational modifications of the protein [7,37,38]. It has
previously been shown that while the N-terminus acts as the
primary membrane binding region undergoing conformational
changes, posttranslational modifications at the protein’s C-
terminus can alter membrane interactions [39]. Several lines of
evidence indicate that asyn phosphorylation inhibits membrane
binding. In both budding yeast and C. elegans, binding of asyn to
plasma membranes is enhanced in the phosphorylation-deficient
S129A mutation, while the phosphorylation mimic S129D shows
decreased membrane binding [16,25]. In our experiments, asyn
pseudophosphorylation at Ser129 showed only a mild inhibitory
effect on monomer binding to DPPC-SUV vesicles. Similar to
wild-type asyn, no interactions with uncharged membranes in the
liquid-crystalline state such as POPC-SUV were seen. This is in
accordance with our previous findings that membrane interaction
is dependent on the membrane surface configuration, requiring a
negative surface charge or a stressed gel-phase to enable monomer
binding [7] (figure 4). In small unilamellar vesicles consisting of
DPPC as applied in the current study, the high membrane
curvature leads to local defects in the vesicle membrane. It was
demonstrated previously that monomeric asyn binds to these
defects, thus leading to local reorganization of lipids [37,40].
In summary, our observation of a mild inhibitory influence of
Ser129 pseudophosphorylation on asyn monomer binding to
DPPC-SUV further corroborates previous findings that phosphor-
ylation inhibits membrane binding of asyn monomers, although
the overall effect appears to be mild. Phosphorylation of
monomeric asyn may thus be a physiological regulatory mecha-
nism to adjust asyn membrane affinity.
Figure 2. Differential influence of Ser129 pseudophosphoryla-
tion on metal-ion induced asyn oligomer formation. A. FIDA
analysis demonstrates an increased proportion of asyn129E647 oligo-
mers within total fluorescence intensity for both Fe3+ and Al3+,
indicating an increased aggregation propensity of asyn129E647 in
presence of both aggregation inducers. B. FIDA two component fit
demonstrates that oligomer sizes do not differ significantly between
asyn and asyn129E. Levels of significance are depicted as * = p,0.05;
n = 3.
doi:10.1371/journal.pone.0098906.g002
Figure 3. Influence of metal-ion induced asyn oligomer
formation and pseudophosphorylation on membrane binding.
A. FIDA analysis (upper panel) and 2D FIDA histograms (lower panel)
demonstrate that Fe3+/Al3+ induced asyn647 oligomers show a high
affinity to POPC-SUV488. Conversely, membrane binding of asyn129E647
oligomers is nearly abolished for Fe3+ and markedly reduced for Al3+
induced oligomers. B. SIFT segment analysis also demonstrates an
increased mixed particle signal for asyn647 as compared to asyn129E647
(‘‘bound oligomer’’, corresponding to SIFT segments 4–15; also see
figure 1A.), while levels of free oligomers are higher in asyn129E647
(‘‘oligo’’, corresponding to segments 16–18). Levels of significance are
depicted as * = p,0.05, ** = p,0.01; n = 3.
doi:10.1371/journal.pone.0098906.g003
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Modeling phosphorylation at Ser129 abolishes
membrane binding of Fe3+ induced asyn oligomers
We have previously demonstrated that Fe3+ induced asyn
oligomers exhibit a potentially pathological gain of function, acting
as membrane pores on lipid surfaces [7,8]. In a model system
applying evaporation to generate asyn oligomers, a similar extent
of membrane permeabilization was found, requiring a high
proportion of negatively charged lipids to facilitate permeabiliza-
tion [41]. In this model, an oligomer structure with a hydrophobic
core composed of the N-terminus including the NAC domain was
proposed, with the C-termini forming an outer shell with
conformational heterogeneity [42,43]. Our current findings
indicate that phosphorylation at Ser129, while enhancing Fe3+
induced oligomer formation, may rescue membrane permeabiliza-
tion by inhibiting oligomer binding to lipid surfaces. In our
experiments, the high affinity of Fe3+ induced asyn oligomers was
almost completely abolished by pseudophosphorylation. These
results are surprising given that earlier studies demonstrated that
interactions between asyn and lipid bilayers mainly occur through
the N-terminal domain. Thus, our findings may point towards a
potential role of the C-terminal domain in membrane interactions,
as was demonstrated for other post-translational modifications
[39]. Conversely, the effects observed could be due to structural
differences between the ferric iron induced oligomers observed
here and asyn oligomers generated by other means.
Of note, binding to POPC membranes was not limited to Fe3+
induced asyn oligomers, but appears to be a common hallmark of
oligomers formed in presence of trivalent metal-ions. A similar,
though less pronounced effect of asyn pseudophosphorylation was
seen in Al3+ induced asyn oligomers, where vesicle binding of
oligomers was reduced to ,20%. While no significant difference
in oligomer size was seen between asyn and asy129E, it is currently
unknown whether mimicking phosphorylation alters the internal
oligomer structure. The sequestration of potentially toxic oligo-
mers from cellular membranes may act as a protective mechanism,
possibly resulting in the formation of larger fibrillar asyn
aggregates without toxic effects (also see figure 4).
In summary, our findings implicate a differential influence of
asyn phosphorylation on aggregation behavior and membrane
binding, as is illustrated in figure 4. Phosphorylation at Ser129
yields a mild inhibitory effect on monomer membrane binding.
While it facilitates oligomer formation in presence of trivalent
metal-ions, membrane binding of the resulting oligomers is
strongly reduced. Thus, the current model suggests that the
protective effect of asyn pseudophosphorylation recently seen in
animal models is due to decreased membrane binding of asyn
oligomers. Moreover, these results indicate that membrane
binding is an essential mediator of neurotoxicity. The increased
aggregation propensity of the phosphorylated protein may, in turn,
lead to sequestration into large inert aggregates such as fibrillar
deposits in form of Lewy bodies.
Importantly, these findings put a new complexion on experi-
mental pharmaceutical interventions directed against POLO-2
kinase, which mediates asyn phosphorylation at Ser129 [44].
Given the potential neuroprotective effect of Ser129 phosphory-
lation, such interventions may not achieve relevant therapeutic
effects.
Supporting Information
Figure S1 Addition of ferric iron does not result in
quenching of Alexa/Bodipy fluorescent dyes. Concentra-
tion series of ferric iron were added to different fluorescent dyes to
investigate potential quenching effects. A/B. In a broad range of
concentrations tested, Fe3+ does not alter particle brightness,
diffusion time or fitted particle number of the fluorescent dye
Alexa-647 as determined by FCS (A) and 1D-FIDA (B) analyses.
C. Upon ligation to the non-amylodiogenic, asyn-specific antibody
15G7, no effect on Alexa-647 readout parameters is detectable in
presence of 10 uM Fe3+. As demonstrated earlier, the aggregation-
inducing effect of the metal ion appears to be specific to
amyloidogenic proteins [35]. D. As observed for Alexa-647, no
effect on readout parameters is detectable upon coincubation of
Bodipy-PE and ferric iron in FIDA analysis. E. / F. Control
experiment using asyn with point mutations to cysteine in positions
3, 81 and 140 and point-specific labeling with Alexa647 maleimide
dyes. E. Oligomer sizes of Fe3+ induced asyn oligomers are
comparable for all three point mutations and in accordance with
randomly labeled wt asyn oligomers as demonstrated earlier [35].
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Figure 4. Schematic illustrating the influence of mimicking
Ser129 phosphorylation on asyn membrane interactions. A. For
stressed gel-state membranes (DPPC-SUV), mimicking phosphorylation
at Ser129 mildly reduces asyn binding affinity. B. Both pseudopho-
sphorylated and unphosphorylated asyn monomers show no affinity to
membranes in the liquid-crystalline state (POPC). C. Fe3+ induced asyn
oligomers show a high membrane affinity and potentially act as
membrane pores. Pseudophosphorylation at Ser129 shows a differential
influence on asyn aggregation and binding behaviour. While increasing
oligomer formation in presence of trivalent metal-ions, Ser129
pseudophosphorylation inhibits membrane binding and may thus
allow oligomer sequestration into larger aggregates such as fibrils.
doi:10.1371/journal.pone.0098906.g004
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